PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDecellularized dermal allograft
Decellularized dermal allograft
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1561 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Kidney transplantationD016030——1435193577172
LeukemiaD007938—C95458519327157
Myeloid leukemia acuteD015470—C92.0284616321100
Myeloid leukemiaD007951—C9225461321689
Graft rejectionD006084——7177104581
Intervertebral disc degenerationD055959——12226470
Renal insufficiencyD051437—N1910118103266
SyndromeD013577——1333431260
UlcerD014456MPATH_579—14—83446
Vascular diseasesD014652EFO_0004264I7714562844
Show 98 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelodysplastic syndromesD009190—D4630557—1698
LymphomaD008223—C85.919583—1886
PreleukemiaD011289——20386—965
Hematologic neoplasmsD019337——22314—1563
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.020305—1259
Multiple myelomaD009101—C90.016371—1259
NeoplasmsD009369—C8017283—1047
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—10234—1042
Non-hodgkin lymphomaD008228—C85.911301—841
Plasma cell neoplasmsD054219——10271—538
Show 48 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hodgkin diseaseD006689—C81922——933
B-cell chronic lymphocytic leukemiaD015451—C91.1719——526
Hematologic diseasesD006402EFO_0005803D75.914——813
T-cell lymphomaD016399——19——312
AtrophyD001284——11——1012
Mantle-cell lymphomaD020522—C83.118——311
PlasmacytomaD010954—C90.338——111
B-cell lymphomaD016393——37——110
Congenital abnormalitiesD000013EFO_0003915Q89.932——59
Large b-cell lymphoma diffuseD016403—C83.326——29
Show 148 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Tooth extractionD014081——1———1415
Low back painD017116—M54.51———78
Back painD001416—M541———78
ArthritisD001168EFO_0005856M05-M141———78
Heart failureD006333EFO_0003144I501———34
Bone transplantationD016025——1———34
ObesityD009765EFO_0001073E66.91———23
Neurogenic urinary bladderD001750HP_0000011N311———23
Lung diseasesD008171EFO_0003818J98.41———23
MelanomaD008545——1———12
Show 23 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PeriodontitisD010518EFO_0000649K05.3————1313
Intervertebral disc displacementD007405EFO_1001800—————99
Spinal cord diseasesD013118—G95.9————88
RadiculopathyD011843—M54.1————88
Heart diseasesD006331EFO_0003777I51.9————88
Dental implantsD015921——————88
Spinal fusionD013123——————66
Joint dislocationsD004204——————66
Congenital heart defectsD006330—Q24.9————66
Patellar dislocationD031222——————55
Show 231 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
12 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use